| Product Code: ETC13167127 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Oral Solid Dosage Forms and Pharma Excipients Market was valued at USD 78 Billion in 2024 and is expected to reach USD 110.5 Billion by 2031, growing at a compound annual growth rate of 6.90% during the forecast period (2025-2031).
The global oral solid dosage forms and pharma excipients market is a key segment within the pharmaceutical industry, encompassing a wide range of products including tablets, capsules, powders, and granules. The market is driven by factors such as the increasing prevalence of chronic diseases, growing geriatric population, and advancements in drug delivery technologies. Moreover, the rising demand for generic drugs and the need for novel drug formulations are fueling market growth. Excipients play a crucial role in oral solid dosage forms by ensuring the stability, bioavailability, and efficacy of the active pharmaceutical ingredients. Major players in this market include Ashland Global Holdings, BASF SE, and DuPont de Nemours, Inc. The market is characterized by ongoing research and development activities aimed at enhancing drug delivery systems and improving patient compliance.
The Global Oral Solid Dosage Forms and Pharma Excipients Market is witnessing a growing demand for innovative dosage forms such as orally disintegrating tablets and extended-release formulations. This shift is driven by the increasing prevalence of chronic diseases and the need for patient-friendly drug delivery systems. Additionally, the market is experiencing a rise in the use of novel excipients to enhance drug stability, bioavailability, and patient compliance. Opportunities abound for pharmaceutical companies to invest in research and development of advanced oral solid dosage forms and excipients to meet the evolving needs of the healthcare industry. The market is also seeing a surge in contract manufacturing and outsourcing services, offering further avenues for growth and collaboration in this dynamic sector.
One of the key challenges faced in the Global Oral Solid Dosage Forms and Pharma Excipients Market is the stringent regulatory environment governing the approval and manufacturing of pharmaceutical products. The need for compliance with various regulations and guidelines across different regions increases the complexity and costs of product development and commercialization. Additionally, the industry faces challenges in sourcing high-quality excipients that meet regulatory standards while also ensuring cost-effectiveness. Moreover, with the rising demand for personalized medicine and complex drug formulations, there is a growing need for innovative excipients that can enhance drug delivery and efficacy. Balancing these regulatory, cost, and innovation challenges is crucial for companies operating in this market to remain competitive and meet the evolving needs of the healthcare industry.
The Global Oral Solid Dosage Forms and Pharma Excipients Market is primarily driven by the increasing prevalence of chronic diseases and the growing geriatric population worldwide, leading to a higher demand for pharmaceutical products in solid dosage forms. Additionally, advancements in drug delivery technologies, rising investments in research and development activities by pharmaceutical companies, and the need for innovative formulations to improve patient compliance and convenience are driving market growth. Furthermore, the expanding generic drug market, the shift towards preventive healthcare, and the rising focus on personalized medicine are also contributing to the increasing adoption of oral solid dosage forms and pharma excipients in the pharmaceutical industry.
Government policies related to the Global Oral Solid Dosage Forms and Pharma Excipients Market focus on ensuring product safety, efficacy, and quality through stringent regulations. Authorities such as the FDA in the United States and the European Medicines Agency in the EU enforce guidelines for the approval and manufacturing of oral solid dosage forms and pharmaceutical excipients. These regulations cover areas such as Good Manufacturing Practices (GMP), labeling requirements, and pharmacovigilance to monitor product safety post-market. Additionally, efforts are being made to streamline approval processes and foster innovation while maintaining high standards of quality and safety to protect public health. Compliance with these regulations is crucial for companies operating in this market to meet market access requirements and maintain consumer trust.
The Global Oral Solid Dosage Forms and Pharma Excipients Market is expected to witness steady growth in the coming years due to factors such as the increasing prevalence of chronic diseases, growing geriatric population, and rising demand for pharmaceutical products worldwide. The market is also likely to benefit from advancements in drug delivery technologies and the development of innovative formulations. Additionally, the emphasis on personalized medicine and the expansion of the pharmaceutical industry in emerging markets are anticipated to drive market growth further. However, challenges such as stringent regulatory requirements and the high costs associated with drug development may hinder the market`s expansion to some extent. Overall, the market is projected to experience sustained growth, with opportunities for companies to innovate and cater to the evolving needs of the healthcare industry.
The Global Oral Solid Dosage Forms and Pharma Excipients Market is experiencing varied growth trends across different regions. In Asia, particularly in countries like China and India, the market is witnessing significant expansion due to the growing pharmaceutical industry and increasing healthcare expenditure. North America is a mature market with a strong presence of key pharmaceutical companies, driving the demand for advanced oral solid dosage forms and pharma excipients. Europe is focusing on innovation and research in drug formulation, leading to the adoption of novel excipients. The Middle East and Africa region is seeing steady growth, supported by government initiatives to enhance healthcare infrastructure. Latin America is experiencing growth due to the rising prevalence of chronic diseases and increasing awareness about oral solid dosage forms and excipients among healthcare professionals and patients.
Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Revenues & Volume, 2021 & 2031F |
3.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market - Industry Life Cycle |
3.4 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market - Porter's Five Forces |
3.5 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Trends |
6 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, 2021 - 2031 |
6.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Glycerin, 2021 - 2031 |
6.1.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Propylene Glycol, 2021 - 2031 |
6.1.4 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Sorbitol, 2021 - 2031 |
6.1.5 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Mannitol, 2021 - 2031 |
6.1.6 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Industrial Application, 2021 - 2031 |
6.2.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Non-industrial Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
7 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Overview & Analysis |
7.1 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Revenues & Volume, 2021 - 2031 |
7.2 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Latin America (LATAM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Overview & Analysis |
8.1 Latin America (LATAM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Application, 2021 - 2031 |
9 Asia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Overview & Analysis |
9.1 Asia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Application, 2021 - 2031 |
10 Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Overview & Analysis |
10.1 Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Application, 2021 - 2031 |
11 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Overview & Analysis |
11.1 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Application, 2021 - 2031 |
12 Middle East Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Overview & Analysis |
12.1 Middle East Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, Revenues & Volume, By Application, 2021 - 2031 |
13 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Key Performance Indicators |
14 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market - Export/Import By Countries Assessment |
15 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market - Opportunity Assessment |
15.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Opportunity Assessment, By Application, 2021 & 2031F |
16 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market - Competitive Landscape |
16.1 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Revenue Share, By Companies, 2024 |
16.2 Global Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |